Fluoroscopic “Lucent Line” Deployment in SAPIEN-3 TAVR is Non-Reproducible with no Impact on Short-Term Outcomes

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Medtronic; Boston Scientific Corporation; Siemens Healthineers; East End Medical LLC
• Advisory Board member - JenaValve